LIFECORE BIOMEDICAL, INC. Repayments of Debt
LIFECORE BIOMEDICAL, INC. (LFCR) reported Repayments of Debt of $67.90 million for the 3-month period ending 2022-02-27, per its 10-K/A filed 2023-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2023-03-16
- LIFECORE BIOMEDICAL, INC. repayments of debt for the quarter ending 2022-02-27 was $67.90M.
| Period end | Repayments of Debt 3 month | Repayments of Debt 9 month |
|---|---|---|
| 2022-02-27 | $67.90M 10-K/A · filed 2023-03-16 | $67.90M 10-Q · filed 2022-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |